-
1
-
-
71649105333
-
Increasing prevalence of atrial fibrillation and flutter in the United States
-
Naccarelli GV, Varker H, Lin J et al. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol. 2009; 104:1534-9.
-
(2009)
Am J Cardiol
, vol.104
, pp. 1534-1539
-
-
Naccarelli, G.V.1
Varker, H.2
Lin, J.3
-
2
-
-
4644309097
-
Antithrombotic therapy in atrial fibrillation: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
-
DOI 10.1378/chest.126.3-suppl.429S
-
Singer DE, Albers GW, Dalen JE et al. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004; 126(suppl 3):429S-456S. (Pubitemid 39302603)
-
(2004)
Chest
, vol.126
, Issue.3 SUPPL.
-
-
Singer, D.E.1
Albers, G.W.2
Dalen, J.E.3
Go, A.S.4
Halperin, J.L.5
Manning, W.J.6
-
3
-
-
33747437950
-
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for practice guidelines (Writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation)
-
DOI 10.1161/CIRCULATIONAHA.106.177292, PII 0000301720060815000022
-
Fuster V, Rydén LE, Cannom DS et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006; 114(7):e257-354. (Pubitemid 44252297)
-
(2006)
Circulation
, vol.114
, Issue.7
-
-
Fuster, V.1
Ryden, L.E.2
Cannom, D.S.3
Crijns, H.J.4
Curtis, A.B.5
Ellenbogen, K.A.6
Halperin, J.L.7
Le, H.J.-Y.8
Kay, G.N.9
Lowe, J.E.10
Olsson, S.B.11
Prystowsky, E.N.12
Tamargo, J.L.13
Wann, S.14
Smith Jr., S.C.15
Jacobs, A.K.16
Adams, C.D.17
Anderson, J.L.18
Antman, E.M.19
Halperin, J.L.20
Hunt, S.A.21
Nishimura, R.22
Ornato, J.P.23
Page, R.L.24
Riegel, B.25
Priori, S.G.26
Blanc, J.-J.27
Budaj, A.28
Camm, A.J.29
Dean, V.30
Deckers, J.W.31
Despres, C.32
Dickstein, K.33
Lekakis, J.34
McGregor, K.35
Metra, M.36
Morais, J.37
Osterspey, A.38
Tamargo, J.L.39
Zamorano, J.L.40
more..
-
4
-
-
45949109467
-
Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition)
-
DOI 10.1378/chest.08-0720
-
Albers GW, Amarenco P, Easton JD et al., for the American College of Chest Physicians. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008; 133(suppl 6):630S-669S. (Pubitemid 351892974)
-
(2008)
Chest
, vol.133
, Issue.6 SUPPL. 6
-
-
Albers, G.W.1
Amarenco, P.2
Easton, J.D.3
Sacco, R.L.4
Teal, P.5
-
5
-
-
79960075350
-
A pharmacoeconomic perspective on stroke prevention in atrial fibrillation
-
Fendrick AM. A pharmacoeconomic perspective on stroke prevention in atrial fibrillation. Am J Manag Care. 2010; 16(suppl 10):S284-90.
-
(2010)
Am J Manag Care
, vol.16
, Issue.SUPPL. 10
-
-
Fendrick, A.M.1
-
6
-
-
33748358147
-
Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States
-
DOI 10.1111/j.1524-4733.2006.00124.x
-
Coyne KS, Paramore C, Grandy S et al. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health. 2006; 9:348-56. (Pubitemid 44337788)
-
(2006)
Value in Health
, vol.9
, Issue.5
, pp. 348-356
-
-
Coyne, K.S.1
Paramore, C.2
Grandy, S.3
Mercader, M.4
Reynolds, M.5
Zimetbaum, P.6
-
8
-
-
33646468354
-
Effect of study setting on anticoagulation control: A systematic review and meta-regression
-
Van Walraven C, Jennings A, Oake N et al. Effect of study setting on anticoagulation control: a systematic review and meta-regression. Chest. 2006; 129:1155-66.
-
(2006)
Chest
, vol.129
, pp. 1155-1166
-
-
Van Walraven, C.1
Jennings, A.2
Oake, N.3
-
9
-
-
65449163045
-
Metaanalysis to assess the quality of warfarin control in atrial fibrillation patients in the United States
-
Baker WL, Cio DA, Sander SD et al. Metaanalysis to assess the quality of warfarin control in atrial fibrillation patients in the United States. J Manag Care Pharm. 2009; 15:244-52.
-
(2009)
J Manag Care Pharm
, vol.15
, pp. 244-252
-
-
Baker, W.L.1
Cio, D.A.2
Sander, S.D.3
-
10
-
-
33947277849
-
The cost of monitoring warfarin in patients with chronic atrial fibrillation in primary care in Sweden
-
Björholt I, Andersson S, Nilsson GH et al. The cost of monitoring warfarin in patients with chronic atrial fibrillation in primary care in Sweden. BMC Fam Pract. 2007; 8:6-13.
-
(2007)
BMC Fam Pract
, vol.8
, pp. 6-13
-
-
Björholt, I.1
Andersson, S.2
Nilsson, G.H.3
-
11
-
-
14044279786
-
Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinic settings: A multi-site managed-care study
-
DOI 10.1345/aph.1E169
-
Menzin J, Boulanger L, Hauch O et al. Quality of anticoagulation control and costs of monitoring warfarin therapy among patients with atrial fibrillation in clinical settings: a multi-site managed-care study. Ann Pharmacother. 2005; 39:446-51. (Pubitemid 40276873)
-
(2005)
Annals of Pharmacotherapy
, vol.39
, Issue.3
, pp. 446-451
-
-
Menzin, J.1
Boulanger, L.2
Hauch, O.3
Friedman, M.4
Marple, C.B.5
Wygant, G.6
Hurley, J.S.7
Pezzella, S.8
Kaatz, S.9
-
12
-
-
77049099324
-
Potentially avoidable inpatient nights among warfarin receiving patients; an audit of a single university teaching hospital
-
Forde D, O'Connor MB, Gilligan O. Potentially avoidable inpatient nights among warfarin receiving patients; an audit of a single university teaching hospital. BMC Res Notes. 2009; 2:41-5.
-
(2009)
BMC Res Notes
, vol.2
, pp. 41-45
-
-
Forde, D.1
O'Connor, M.B.2
Gilligan, O.3
-
13
-
-
79451472118
-
Cost efficiency of anticoagulation with warfarin to prevent stroke in Medicare beneficiaries with nonvalvular atrial fibrillation
-
Mercaldi CJ, Ciarametaro M, Hahn B et al. Cost efficiency of anticoagulation with warfarin to prevent stroke in Medicare beneficiaries with nonvalvular atrial fibrillation. Stroke. 2011; 42:112-8.
-
(2011)
Stroke
, vol.42
, pp. 112-118
-
-
Mercaldi, C.J.1
Ciarametaro, M.2
Hahn, B.3
-
14
-
-
27144458795
-
Economic burden and co-morbidities of atrial fibrillation in a privately insured population
-
DOI 10.1185/030079905X65475, 3081
-
Wu EQ, Birnbaum HG, Mareva M et al. Economic burden and co-morbidities of atrial fibrillation in a privately insured population. Curr Med Res Opin. 2005; 21:1693-9. (Pubitemid 41505035)
-
(2005)
Current Medical Research and Opinion
, vol.21
, Issue.10
, pp. 1693-1699
-
-
Wu, E.Q.1
Birnbaum, H.G.2
Mareva, M.3
Tuttle, E.4
Castor, A.R.5
Jackman, W.6
Ruskin, J.7
-
15
-
-
33744482871
-
-
Joint Commission. (accessed 2011 Apr 7)
-
Joint Commission. 2010 National Patient Safety Goals. www.jcrinc.com/Joint-Commission-Requirements/Hospitals/ (accessed 2011 Apr 7).
-
(2010)
National Patient Safety Goals
-
-
-
17
-
-
0034946345
-
The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed
-
DOI 10.1053/jhin.2000.0881
-
Plowman R, Graves N, Griffin MA et al. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect. 2001; 47:198-209. (Pubitemid 32631848)
-
(2001)
Journal of Hospital Infection
, vol.47
, Issue.3
, pp. 198-209
-
-
Plowman, R.1
Graves, N.2
Griffin, M.A.S.3
Roberts, J.A.4
Swan, A.V.5
Cookson, B.6
Taylor, L.7
-
18
-
-
77949910338
-
Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia
-
Eber MR, Laxminarayan R, Perencevich EN et al. Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia. Arch Intern Med. 2010; 170:347-53.
-
(2010)
Arch Intern Med
, vol.170
, pp. 347-353
-
-
Eber, M.R.1
Laxminarayan, R.2
Perencevich, E.N.3
|